Metastatic sites as predictors in advanced NSCLC treated with PD-1 inhibitors: a systematic review and meta-analysis

• Asıl Yazarlar: Yangyun Huang (Yazar), Lihuan Zhu (Yazar), Tianxing Guo (Yazar), Wenshu Chen (Yazar), Zhenlong Zhang (Yazar), Wujin Li (Yazar), Xiaojie Pan (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Taylor & Francis Group, 2021-05-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background Programmed cell death protein 1 (PD-1) inhibitors are the first-line treatment for advanced non-small-cell lung cancer (NSCLC) patients. However, their efficacy in metastatic NSCLC patients remains controversial. Aim of the study The aim of our study was to evaluate the prognosis of advan...